ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

Outcomes of As-Needed Aflibercept Treatment After Complete Regression in Polypoidal Choroidal Vasculopathy

Study limitation reported by the research below: “Only 26 of 81 enrolled eyes were evaluable for the primary analysis, limiting statistical power and precision of the recurrence estimates.”

Papers